{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T04:52:51Z","timestamp":1781671971593,"version":"3.54.5"},"reference-count":27,"publisher":"Norwegian Medical Association","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Tidsskr Nor Legeforen","Tidsskriftet"],"published-print":{"date-parts":[[2010,3,25]]},"DOI":"10.4045\/tidsskr.08.0558","type":"journal-article","created":{"date-parts":[[2010,3,26]],"date-time":"2010-03-26T08:21:11Z","timestamp":1269591671000},"page":"601","source":"Crossref","is-referenced-by-count":0,"title":["Ny kunnskap om Creutzfeldt-Jakobs sykdom kan gi terapeutiske muligheter"],"prefix":"10.4045","volume":"130","author":[{"given":"Torger","family":"St\u00f8lsmark","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ole-Bj\u00f8rn","family":"Tysnes","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2479","reference":[{"key":"ref=1","doi-asserted-by":"crossref","unstructured":"Ladogana A, Puopolo M, Croes EA et al. Mortality from Creutzfeldt-Jakob disease and related disorders in Europe, Australia, and Canada. Neurology 2005; 64: 1586\u2009\u2013\u200991.","DOI":"10.1212\/01.WNL.0000160117.56690.B2"},{"key":"ref=2","doi-asserted-by":"crossref","unstructured":"Will RG. Acquired prion disease: iatrogenic CJD, variant CJD, kuru. Br Med Bull 2003; 66: 255\u2009\u2013\u200965.","DOI":"10.1093\/bmb\/66.1.255"},{"key":"ref=3","doi-asserted-by":"crossref","unstructured":"Pocchiari M. Prevalence of variant CJD in the UK. BMJ 2009; 338: b435.","DOI":"10.1136\/bmj.b435"},{"key":"ref=4","doi-asserted-by":"crossref","unstructured":"Llewelyn CA, Hewitt PE, Knight RS et al. Possible transmission of variant Creutzfeldt-Jakob disease by blood transfusion. Lancet 2004; 363: 417\u2009\u2013\u200921.","DOI":"10.1016\/S0140-6736(04)15486-X"},{"key":"ref=5","doi-asserted-by":"crossref","unstructured":"Farbu E, Tysnes OB, Mork S et al. Two Norwegian sisters with late onset Creutzfeldt-Jakob disease caused by the E200K mutation. J Neurol 2007; 254: 262\u2009\u2013\u20093.","DOI":"10.1007\/s00415-006-0363-0"},{"key":"ref=6","doi-asserted-by":"crossref","unstructured":"Mallucci GR, White MD, Farmer M et al. Targeting cellular prion protein reverses early cognitive deficits and neurophysiological dysfunction in prion-infected mice. Neuron 2007; 53: 325\u2009\u2013\u200935.","DOI":"10.1016\/j.neuron.2007.01.005"},{"key":"ref=7","doi-asserted-by":"crossref","unstructured":"Prusiner SB. Prions. Proc Natl Acad Sci U S A 1998; 95: 13363\u2009\u2013\u200983.","DOI":"10.1073\/pnas.95.23.13363"},{"key":"ref=8","doi-asserted-by":"crossref","unstructured":"Mallucci GR, Ratte S, Asante EA et al. Post-natal knockout of prion protein alters hippocampal CA1 properties, but does not result in neurodegeneration. Embo J 2002; 21: 202\u2009\u2013\u200910.","DOI":"10.1093\/emboj\/21.3.202"},{"key":"ref=9","doi-asserted-by":"crossref","unstructured":"Mallucci G, Dickinson A, Linehan J et al. Depleting neuronal PrP in prion infection prevents disease and reverses spongiosis. Science 2003; 302: 871\u2009\u2013\u20094.","DOI":"10.1126\/science.1090187"},{"key":"ref=10","doi-asserted-by":"crossref","unstructured":"Li CX, Parker A, Menocal E et al. Delivery of RNA interference. Cell Cycle 2006; 5: 2103\u2009\u2013\u20099.","DOI":"10.4161\/cc.5.18.3192"},{"key":"ref=11","doi-asserted-by":"crossref","unstructured":"Pfeifer A, Eigenbrod S, Al-Khadra S et al. Lentivector-mediated RNAi efficiently suppresses prion protein and prolongs survival of scrapie-infected mice. J Clin Invest 2006; 116: 3204\u2009\u2013\u200910.","DOI":"10.1172\/JCI29236"},{"key":"ref=12","doi-asserted-by":"crossref","unstructured":"White MD, Farmer M, Mirabile I et al. Single treatment with RNAi against prion protein rescues early neuronal dysfunction and prolongs survival in mice with prion disease. Proc Natl Acad Sci U S A 2008; 105: 10238\u2009\u2013\u200943.","DOI":"10.1073\/pnas.0802759105"},{"key":"ref=13","doi-asserted-by":"crossref","unstructured":"Kato S, Inoue K, Kobayashi K et al. Efficient gene transfer via retrograde transport in rodent and primate brains using a human immunodeficiency virus type 1-based vector pseudotyped with rabies virus glycoprotein. Hum Gene Ther 2007; 18: 1141\u2009\u2013\u200951.","DOI":"10.1089\/hum.2007.082"},{"key":"ref=14","doi-asserted-by":"crossref","unstructured":"Oh S, Odland R, Wilson SR et al. Improved distribution of small molecules and viral vectors in the murine brain using a hollow fiber catheter. J Neurosurg 2007; 107: 568\u2009\u2013\u200977.","DOI":"10.3171\/JNS-07\/09\/0568"},{"key":"ref=15","doi-asserted-by":"crossref","unstructured":"Ishibashi D, Yamanaka H, Yamaguchi N et al. Immunization with recombinant bovine but not mouse prion protein delays the onset of disease in mice inoculated with a mouse-adapted prion. Vaccine 2007; 25: 985\u2009\u2013\u200992.","DOI":"10.1016\/j.vaccine.2006.09.078"},{"key":"ref=16","doi-asserted-by":"crossref","unstructured":"White AR, Enever P, Tayebi M et al. Monoclonal antibodies inhibit prion replication and delay the development of prion disease. Nature 2003; 422: 80\u2009\u2013\u20093.","DOI":"10.1038\/nature01457"},{"key":"ref=17","doi-asserted-by":"crossref","unstructured":"Solforosi L, Criado JR, McGavern DB et al. Cross-linking cellular prion protein triggers neuronal apoptosis in vivo. Science 2004; 303: 1514\u2009\u2013\u20096.","DOI":"10.1126\/science.1094273"},{"key":"ref=18","doi-asserted-by":"crossref","unstructured":"Kocisko DA, Baron GS, Rubenstein R et al. New inhibitors of scrapie-associated prion protein formation in a library of 2000 drugs and natural products. J Virol 2003; 77: 10288\u2009\u2013\u200994.","DOI":"10.1128\/JVI.77.19.10288-10294.2003"},{"key":"ref=19","doi-asserted-by":"crossref","unstructured":"Doh-ura K, Ishikawa K, Murakami-Kubo I et al. Treatment of transmissible spongiform encephalopathy by intraventricular drug infusion in animal models. J Virol 2004; 78: 4999\u2009\u2013\u20095006.","DOI":"10.1128\/JVI.78.10.4999-5006.2004"},{"key":"ref=20","doi-asserted-by":"crossref","unstructured":"Shyng SL, Lehmann S, Moulder KL et al. Sulfated glycans stimulate endocytosis of the prion protein, PrPC, in cultured cells. J Biol Chem 1995; 270: 30221\u2009\u2013\u20099.","DOI":"10.1074\/jbc.270.50.30221"},{"key":"ref=21","doi-asserted-by":"crossref","unstructured":"Rainov NG, Tsuboi Y, Krolak-Salmon P et al. Experimental treatments for human transmissible spongiform encephalopathies: is there a role for pentosan polysulfate? Expert Opin Biol Ther 2007; 7: 713\u2009\u2013\u200926.","DOI":"10.1517\/14712598.7.5.713"},{"key":"ref=22","doi-asserted-by":"crossref","unstructured":"Bone I, Belton L, Walker AS et al. Intraventricular pentosan polysulphate in human prion diseases: an observational study in the UK. Eur J Neurol 2008; 15: 458\u2009\u2013\u200964.","DOI":"10.1111\/j.1468-1331.2008.02108.x"},{"key":"ref=23","doi-asserted-by":"crossref","unstructured":"Pocchiari M, Puopolo M, Croes EA et al. Predictors of survival in sporadic Creutzfeldt-Jakob disease and other human transmissible spongiform encephalopathies. Brain 2004; 127: 2348\u2009\u2013\u200959.","DOI":"10.1093\/brain\/awh249"},{"key":"ref=24","doi-asserted-by":"crossref","unstructured":"Roesler R, Walz R, Quevedo J et al. Normal inhibitory avoidance learning and anxiety, but increased locomotor activity in mice devoid of PrP(C). Brain Res Mol Brain Res 1999; 71: 349\u2009\u2013\u200953.","DOI":"10.1016\/S0169-328X(99)00193-X"},{"key":"ref=25","doi-asserted-by":"crossref","unstructured":"Criado JR, Sanchez-Alavez M, Conti B et al. Mice devoid of prion protein have cognitive deficits that are rescued by reconstitution of PrP in neurons. Neurobiol Dis 2005; 19: 255\u2009\u2013\u200965.","DOI":"10.1016\/j.nbd.2005.01.001"},{"key":"ref=26","doi-asserted-by":"crossref","unstructured":"Curtis J, Errington M, Bliss T et al. Age-dependent loss of PTP and LTP in the hippocampus of PrP-null mice. Neurobiol Dis 2003; 13: 55\u2009\u2013\u200962.","DOI":"10.1016\/S0969-9961(03)00017-2"},{"key":"ref=27","doi-asserted-by":"crossref","unstructured":"Brown DR, Schulz-Schaeffer WJ, Schmidt B et al. Prion protein-deficient cells show altered response to oxidative stress due to decreased SOD-1 activity. Exp Neurol 1997; 146: 104\u2009\u2013\u200912.","DOI":"10.1006\/exnr.1997.6505"}],"container-title":["Tidsskrift for Den norske legeforening"],"original-title":[],"language":"no","deposited":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T04:03:23Z","timestamp":1781669003000},"score":1,"resource":{"primary":{"URL":"https:\/\/tidsskriftet.no\/2010\/03\/oversiktsartikkel\/ny-kunnskap-om-creutzfeldt-jakobs-sykdom-kan-gi-terapeutiske-muligheter"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,3,25]]},"references-count":27,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2010,3,25]]}},"URL":"https:\/\/doi.org\/10.4045\/tidsskr.08.0558","relation":{},"ISSN":["0029-2001","0807-7096"],"issn-type":[{"value":"0029-2001","type":"print"},{"value":"0807-7096","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,3,25]]}}}